Live News EQUITY L impact Jul 01, 2026, 12:15 PM UTC

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $38 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Pacira BioSciences (NASDAQ: PCRX ) with a Buy and maintains $38 price target.

SQUAWKNEWS Updated Jul 01, 2026, 12:15 PM UTC

HC Wainwright & Co. analyst Douglas Tsao reiterates Pacira BioSciences (NASDAQ: PCRX ) with a Buy and maintains $38 price target.